Lobna, I., Nancy, D.G., Libby, J., et al. (2012) A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients with Treat-ment-Resistant Major Depressive Disorder. Journal of Clinical Psychopharmacology, 32, 551-557.